Cost minimization analysis of two chemotherapy regimens in the treatment of colorectal cancer in a public reimbursement hospital in Brazil
Objective: To conduct a pharmacoeconomic evaluation between XELOX and mFOLFOX6 in the adjuvant and metastatic treatment of colorectal cancer from the perspective of a public reimbursement hospital. Methods: The cost minimization analysis was conducted for patients who started treatment in 2013 and...
Saved in:
Main Authors: | Sara C. BOSCATO, Márcia R. GODOY, Isabela HEINECK |
---|---|
Format: | article |
Language: | EN PT |
Published: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/dcac267a47ea48cb9ed155b9b1f77a35 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interventions performed by clinical pharmacist in the renal transplant ambulatory care
by: Diego Gnatta, et al.
Published: (2020) -
Guest editorial: The ten most important qualities for the profession of medicinal research
by: Tony Y. Zhang
Published: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
by: Nicole D. Avant
Published: (2021) -
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
by: Manal Mohammed Younus, et al.
Published: (2021) -
Pharmacy-Based Point-of-Care Testing: How a “Standard of Care” Approach Can Facilitate Sustainability
by: Alex J. Adams, et al.
Published: (2021)